{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T20:00:01Z","timestamp":1791576001137,"version":"4.3.4"},"reference-count":60,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","award":["IG14727"],"award-info":[{"award-number":["IG14727"]}],"id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004486","name":"Fondazione Cassa di Risparmio di Perugia","doi-asserted-by":"publisher","award":["2017.0194.021"],"award-info":[{"award-number":["2017.0194.021"]}],"id":[{"id":"10.13039\/501100004486","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.bbagrm.2020.194481","type":"journal-article","created":{"date-parts":[[2020,1,8]],"date-time":"2020-01-08T00:43:50Z","timestamp":1578444230000},"page":"194481","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"title":["Molecular mechanisms underlying eicosapentaenoic acid inhibition of HDAC1 and DNMT expression and activity in carcinoma cells"],"prefix":"10.1016","volume":"1863","author":[{"given":"Veronica","family":"Ceccarelli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Ronchetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Cristina","family":"Marchetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Calvitti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Riccardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Grignani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alba","family":"Vecchini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbagrm.2020.194481_bb0005","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.cell.2012.06.013","article-title":"Cancer epigenetics: from mechanism to therapy","volume":"150","author":"Dawson","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.bbagrm.2020.194481_bb0010","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1158\/1535-7163.MCT-08-0860","article-title":"Epigenetics in cancer: targeting chromatin modifications","volume":"8","author":"Ellis","year":"2009","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.bbagrm.2020.194481_bb0015","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.2174\/092986710791111161","article-title":"Flavonoids influence epigenetic-modifying enzyme activity: structure \u2013 function relationships and the therapeutic potential for cancer","volume":"17","author":"Gilbert","year":"2010","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.bbagrm.2020.194481_bb0020","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1177\/153537020422901002","article-title":"DNA methylation, cancer susceptibility, and nutrient interactions","volume":"229","author":"Davis","year":"2004","journal-title":"Exp. Biol. Med. (Maywood)"},{"key":"10.1016\/j.bbagrm.2020.194481_bb0025","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0092-8674(00)81683-9","article-title":"The hallmarks of cancer","volume":"100","author":"Hanahan","year":"2000","journal-title":"Cell"},{"key":"10.1016\/j.bbagrm.2020.194481_bb0030","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1038\/35010000","article-title":"CpG methylation is maintained in human cancer cells lacking DNMT1","volume":"404","author":"Rhee","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.bbagrm.2020.194481_bb0035","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/0022-2836(87)90689-9","article-title":"CpG islands in vertebrate genomes","volume":"196","author":"Gardiner-Garden","year":"1987","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.bbagrm.2020.194481_bb0040","doi-asserted-by":"crossref","first-page":"2571","DOI":"10.1007\/s00018-004-4201-1","article-title":"Biochemistry and biology of mammalian DNA methyltransferases","volume":"61","author":"Hermann","year":"2004","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.bbagrm.2020.194481_bb0045","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1101\/gad.276568.115","article-title":"Role of TET enzymes in DNA methylation, development, and cancer","volume":"30","author":"Rasmussen","year":"2016","journal-title":"Genes Dev."},{"key":"10.1016\/j.bbagrm.2020.194481_bb0050","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/nrg3080","article-title":"Uncovering the role of 5-hydroxymethylcytosine in the epigenome","volume":"13","author":"Branco","year":"2011","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.bbagrm.2020.194481_bb0055","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1038\/nature10008","article-title":"Dynamic regulation of 5-hydroxymethylcytosine in mouse ES cells and during differentiation","volume":"473","author":"Ficz","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.bbagrm.2020.194481_bb0060","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1126\/science.1210597","article-title":"Tet proteins can convert 5-methylcytosine to 5-formylcytosine and 5-carboxylcytosine","volume":"333","author":"Ito","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.bbagrm.2020.194481_bb0065","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/j.cell.2012.07.033","article-title":"Loss of 5-hydroxymethylcytosine is an epigenetic hallmark of melanoma","volume":"150","author":"Lian","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.bbagrm.2020.194481_bb0070","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/onc.2012.67","article-title":"Tumor-development is associated with decrease of TET gene expression and 5-methylcytosine hydroxylation","volume":"32","author":"Yang","year":"2013","journal-title":"Oncogene"},{"key":"10.1016\/j.bbagrm.2020.194481_bb0075","doi-asserted-by":"crossref","first-page":"925","DOI":"10.14348\/molcells.2015.0294","article-title":"Functions of TET proteins in hematopoietic transformation","volume":"38","author":"Han","year":"2015","journal-title":"Mol. Cells"},{"key":"10.1016\/j.bbagrm.2020.194481_bb0080","doi-asserted-by":"crossref","first-page":"5310","DOI":"10.1038\/sj.onc.1210599","article-title":"HATs and HDACs: from structure, function and regulation to novel strategies for therapy and prevention","volume":"26","author":"Yang","year":"2007","journal-title":"Oncogene"},{"key":"10.1016\/j.bbagrm.2020.194481_bb0085","first-page":"309","article-title":"Histone acetylation and deacetylation","volume":"44","author":"Ito","year":"2000","journal-title":"Methods Mol. Med."},{"key":"10.1016\/j.bbagrm.2020.194481_bb0090","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1002\/(SICI)1521-1878(199808)20:8<615::AID-BIES4>3.0.CO;2-H","article-title":"Roles of histone acetyltransferases and deacetylases in gene regulation","volume":"20","author":"Kuo","year":"1998","journal-title":"Bioessays"},{"key":"10.1016\/j.bbagrm.2020.194481_bb0095","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/B978-0-12-380866-0.60003-4","article-title":"Histone modifications and cancer","volume":"70","author":"Sawan","year":"2010","journal-title":"Adv. Genet."},{"key":"10.1016\/j.bbagrm.2020.194481_bb0100","doi-asserted-by":"crossref","first-page":"8302","DOI":"10.1128\/MCB.22.23.8302-8319.2002","article-title":"Inhibitors of histone deacetylase and DNA methyltransferase synergically activate the methylated metallothionein I promoter by activating the transcription factor MTF-1 and forming an open chromatin structure","volume":"22","author":"Ghoshal","year":"2002","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.bbagrm.2020.194481_bb0105","doi-asserted-by":"crossref","first-page":"469","DOI":"10.4103\/0973-1482.137937","article-title":"Epigenetic therapy of cancer with histone deacetylase inhibitors","volume":"10","author":"Lakshmaiah","year":"2014","journal-title":"J. Cancer Res. Ther."},{"key":"10.1016\/j.bbagrm.2020.194481_bb0110","doi-asserted-by":"crossref","first-page":"2448","DOI":"10.2174\/1568026619666181120150122","article-title":"DNA methyltransferase inhibitors and their therapeutic potential","volume":"18","author":"Zhou","year":"2018","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.bbagrm.2020.194481_bb0115","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.pharmthera.2013.12.015","article-title":"Epigenetic drugs as immunomodulators for combination therapies in solid tumors","volume":"142","author":"Sigalotti","year":"2014","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.bbagrm.2020.194481_bb0120","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1158\/0008-5472.CAN-15-2125","article-title":"Combining epigenetic and immunotherapy to combat cancer","volume":"76","author":"Chiappinelli","year":"2016","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbagrm.2020.194481_bb0125","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1002\/ijc.28865","article-title":"SGI-110 and entinostat therapy reduces lung tumor burden and reprograms the epigenome","volume":"135","author":"Tellez","year":"2014","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.bbagrm.2020.194481_bb0130","doi-asserted-by":"crossref","first-page":"11858","DOI":"10.18632\/oncotarget.24405","article-title":"Effects of the polyunsaturated fatty acids, EPA and DHA, on hematological malignancies: a systematic review","volume":"9","author":"Moloudizargari","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.bbagrm.2020.194481_bb0135","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/bjc.2012.586","article-title":"Marine polyunsaturated fatty acids and cancer therapy","volume":"108","author":"Vaughan","year":"2013","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.bbagrm.2020.194481_bb0140","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s10555-015-9572-2","article-title":"Omega-3 polyunsaturated fatty acids and cancer: lessons learned from clinical trials","volume":"34","author":"Nabavi","year":"2015","journal-title":"Cancer Metastasis Rev."},{"key":"10.1016\/j.bbagrm.2020.194481_bb0145","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.prostaglandins.2014.07.002","article-title":"\u03c9-3 polyunsaturated fatty acids-derived lipid metabolites on angiogenesis, inflammation and cancer","volume":"113-115","author":"Wang","year":"2014","journal-title":"Prostaglandins Other Lipid Mediat"},{"key":"10.1016\/j.bbagrm.2020.194481_bb0150","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1194\/jlr.M300455-JLR200","article-title":"Formation and antiproliferative effect of prostaglandin E(3) from eicosapentaenoic acid in human lung cancer cells","volume":"45","author":"Yang","year":"2004","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bbagrm.2020.194481_bb0155","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.canlet.2014.03.010","article-title":"Prostaglandin E3 metabolism and cancer","volume":"348","author":"Yang","year":"2014","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bbagrm.2020.194481_bb0160","doi-asserted-by":"crossref","first-page":"27092","DOI":"10.1074\/jbc.M111.253609","article-title":"Eicosapentaenoic acid demethylates a single CpG that mediates expression of tumor suppressor CCAAT\/enhancer-binding protein delta in U937 leukemia cells","volume":"286","author":"Ceccarelli","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbagrm.2020.194481_bb0165","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0085025","article-title":"Eicosapentaenoic acid activates RAS\/ERK\/C\/EBP\u03b2 pathway through H-Ras intron 1 CpG island demethylation in U937 leukemia cells","volume":"9","author":"Ceccarelli","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.bbagrm.2020.194481_bb0170","doi-asserted-by":"crossref","first-page":"5990","DOI":"10.1096\/fj.201800245R","article-title":"Eicosapentaenoic acid induces DNA demethylation in carcinoma cells through a TET1-dependent mechanism","volume":"32","author":"Ceccarelli","year":"2018","journal-title":"FASEB J."},{"key":"10.1016\/j.bbagrm.2020.194481_bb0175","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.ejphar.2017.08.045","article-title":"Activation of PPAR\u03b3 inhibits HDAC1-mediated pulmonary arterial smooth muscle cell proliferation and its potential mechanisms","volume":"814","author":"Li","year":"2017","journal-title":"Europ. J. Pharmacol."},{"key":"10.1016\/j.bbagrm.2020.194481_bb0180","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/1756-8722-6-53","article-title":"Histone deacetylase inhibitor potentiated the ability of MTOR inhibitor to induce autophagic cell death in Burkitt leukemia\/lymphoma","volume":"6","author":"Dong","year":"2013","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.bbagrm.2020.194481_bb0185","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/j.bbrc.2008.03.019","article-title":"Inhibition of histone deacetylase1 induces autophagy","volume":"369","author":"Oh","year":"2008","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbagrm.2020.194481_bb0190","doi-asserted-by":"crossref","first-page":"4727","DOI":"10.1128\/MCB.25.11.4727-4741.2005","article-title":"5-aza-deoxycytidine induces selective degradation of DNA methyltransferase 1 by a proteasomal pathway that requires the KEN box, bromo-adjacent homology domain, and nuclear localization signal","volume":"25","author":"Ghoshal","year":"2005","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.bbagrm.2020.194481_bb0195","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/77083","article-title":"Epigenetic inactivation of a RAS association domain family protein from the lung tumor suppressor locus 3p21.3","volume":"25","author":"Dammann","year":"2000","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbagrm.2020.194481_bb0200","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1038\/nm0695-570","article-title":"p53 activates expression of Hic-1, a new candidate tumour suppressor gene on 17p13.3","volume":"1","author":"Wales","year":"1995","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbagrm.2020.194481_bb0205","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1023\/A:1006797522521","article-title":"Tissue inhibitors of metalloproteases: regulation and biological activities","volume":"18","author":"Fassina","year":"2000","journal-title":"Clin. Exp. Metastasis"},{"key":"10.1016\/j.bbagrm.2020.194481_bb0210","first-page":"1241","article-title":"DNA cytosine methylation profile in various cancer-related genes is altered in cultured rat hepatocyte cell lines as compared with primary hepatocytes","volume":"15","author":"Asada","year":"2006","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.bbagrm.2020.194481_bb0215","article-title":"HDAC1 inactivation induces mitotic defect and caspase-independent autophagic cell death in liver cancer","volume":"7","author":"Xie","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.bbagrm.2020.194481_bb0220","doi-asserted-by":"crossref","first-page":"18030","DOI":"10.1073\/pnas.0408345102","article-title":"Apoptotic and autophagic cell death induced by histone deacetylase inhibitors","volume":"101","author":"Shao","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbagrm.2020.194481_bb0225","first-page":"51","article-title":"Chromatin modulation by histone deacetylase inhibitors: impact on cellular sensitivity to ionizing radiation","volume":"5","author":"Carrier","year":"2013","journal-title":"Mol. Cell. Pharmacol."},{"key":"10.1016\/j.bbagrm.2020.194481_bb0230","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1097\/PPO.0000000000000284","article-title":"Targeting histone acetylation: reader and writers in leukemia and cancer","volume":"23","author":"Benton","year":"2017","journal-title":"Cancer J."},{"key":"10.1016\/j.bbagrm.2020.194481_bb0235","doi-asserted-by":"crossref","first-page":"6479","DOI":"10.1038\/sj.onc.1206774","article-title":"Cancer epigenetics","volume":"22","author":"Monparler","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.bbagrm.2020.194481_bb0240","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1038\/nrm.2017.47","article-title":"Understanding nucleosomi dynamics and their links to gene expression and DNA replication","volume":"18","author":"Lai","year":"2017","journal-title":"Nat. Rev. Mol. Cell. Biol."},{"key":"10.1016\/j.bbagrm.2020.194481_bb0245","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1002\/jcb.20738","article-title":"Epigenetic regulation of metallothionein-I gene expression: differential regulation of methylated and unmethylated promoters by DNA methyltransferase and methyl CpG binding proteins","volume":"97","author":"Majumder","year":"2006","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.bbagrm.2020.194481_bb0250","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.canlet.2008.08.016","article-title":"HDAC family: what are the cancer relevant targets?","volume":"277","author":"Witt","year":"2009","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bbagrm.2020.194481_bb0255","doi-asserted-by":"crossref","first-page":"4555","DOI":"10.1128\/MCB.16.8.4555","article-title":"De novo methylation of CpG island sequences in human fibroblasts overexpressing DNA (cytosine-5-)-methyltrasferase","volume":"16","author":"Vertino","year":"1996","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.bbagrm.2020.194481_bb0260","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1080\/13543776.2016.1209488","article-title":"DNA methyltransferase inhibitors: an updated patent review (2012-2015)","volume":"26","author":"Xu","year":"2016","journal-title":"Expert. Opin. Ther. Pat."},{"key":"10.1016\/j.bbagrm.2020.194481_bb0265","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.ccell.2016.09.002","article-title":"Enhancing the cytotoxic effects of PARP inhibitors with DNA demethylating agents \u2013 a potential terapy for cancer","volume":"30","author":"Muvarak","year":"2016","journal-title":"Cancer Cell"},{"issue":"2017","key":"10.1016\/j.bbagrm.2020.194481_bb0270","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1080\/13543776.2017.1259413","article-title":"PARP inhibitors as antitumor agents: a patent undate (2013-2015)","volume":"27","author":"Yuan","year":"2017","journal-title":"Expert. Opin. Ther. Pat."},{"key":"10.1016\/j.bbagrm.2020.194481_bb0275","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1038\/nrclinonc.2013.42","article-title":"The future of epigenetic therapy in solid tumors- lessons from the past","volume":"10","author":"Azad","year":"2013","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.bbagrm.2020.194481_bb0280","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1053\/j.seminhematol.2007.11.007","article-title":"DNA methyltransferase and histone deacetylase inhibitors in the treatment of myelodysplastic syndrome","volume":"45","author":"Griffiths","year":"2008","journal-title":"Semin. Hematol."},{"key":"10.1016\/j.bbagrm.2020.194481_bb0285","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.plefa.2016.10.001","article-title":"Long-chain polyunsaturated fatty acids regulation of PPARs, signaling: relationship to tissue development and aging","volume":"114","author":"Echeverria","year":"2016","journal-title":"Prostaglandins Leukot. Essent. Fatthy Acids."},{"key":"10.1016\/j.bbagrm.2020.194481_bb0290","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.gene.2018.01.018","article-title":"The influence of peroxisome proliferator-activated receptor \u03b3 (PPAR\u03b3) ligands on cancer cell tumorigenicity","volume":"640","author":"Yousefnia","year":"2018","journal-title":"Gene"},{"key":"10.1016\/j.bbagrm.2020.194481_bb0295","doi-asserted-by":"crossref","first-page":"60704","DOI":"10.18632\/oncotarget.19610","article-title":"Peroxisome proliferator-activated receptors (PPARs) are potential drug targets for cancer therapy","volume":"8","author":"Gou","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.bbagrm.2020.194481_bb0300","first-page":"946943","article-title":"The key to unlocking the chemioterapeutic popential of PPAR\u03b3 ligands: having the right combination","author":"Skelhorne-Gross","year":"2012","journal-title":"PPAR Res."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1874939919303876?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1874939919303876?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T13:25:05Z","timestamp":1761744305000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1874939919303876"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":60,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["S1874939919303876"],"URL":"https:\/\/doi.org\/10.1016\/j.bbagrm.2020.194481","relation":{},"ISSN":["1874-9399"],"issn-type":[{"value":"1874-9399","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Molecular mechanisms underlying eicosapentaenoic acid inhibition of HDAC1 and DNMT expression and activity in carcinoma cells","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbagrm.2020.194481","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"194481"}}